Findings
SECONDARY
This secondary analysis of a randomized clinical trial involving 1137 neonates found that neonates receiving NIPPV or NHFOV had fewer reintubations (range, −28% to −15%), fewer early (within 48 hours after extubation) reintubations (range, −24% to −20%), and shorter duration of IMV (range, −5.0 to −2.3 days) than those supported with NCPAP.